Our in-house unique approach is the integration of Chemistry, Biology and Project Management, through which we can efficiently deliver candidate molecules for development with in vitro and in vivo data.
Based on more than 20 year’s experience of drug discovery and development we can offer innovative experimental designs combining efficacy, toxicology and pharmacokinetic end-points in one study or using multivariate statistical frameworks to examine multiple end-points in a single study design. RxCelerate delivers cutting-edge development capability with maximal flexibility, cost-efficiency and accelerated timelines to client companies large and small.
